Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 1.70
Day High 2.22
Open:1.91
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial Fibrillation, Hospital Acquired Pneumonia & Community Acquired Pneumonia, Pulmonary Arterial Hypertension, and Supraventricular Tachycardia. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference
- PR Newswire - Mon Nov 25, 7:00AM CST
PR Newswire - CMTX
Mon Nov 25, 7:00AM CST
NASDAQ: CORV TSX: CORV
Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting
- PR Newswire - Mon Nov 18, 7:00AM CST
PR Newswire - CMTX
Mon Nov 18, 7:00AM CST
NASDAQ: CORV TSX: CORV
Correvio Reports Third Quarter 2019 Financial Results
- PR Newswire - Thu Nov 14, 6:00AM CST
PR Newswire - CMTX
Thu Nov 14, 6:00AM CST
NASDAQ: CORV TSX: CORV
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.70 +2.35% increase
on 12/06/19
Period Open:3.19
Price movement based on the high, low and last over the given period.
3.42 -49.12% decrease
on 11/07/19
-1.45 (-45.45%) decrease
since 11/06/19
3-Month 1.70 +2.35% increase
on 12/06/19
Period Open:2.83
Price movement based on the high, low and last over the given period.
3.66 -52.46% decrease
on 09/13/19
-1.09 (-38.52%) decrease
since 09/06/19
52-Week 1.70 +2.35% increase
on 12/06/19
Period Open:4.53
Price movement based on the high, low and last over the given period.
5.87 -70.36% decrease
on 03/13/19
-2.79 (-61.59%) decrease
since 12/06/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies